(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stock index e-mini futures were higher on Wednesday ahead of a widely expected hike in interest rates by the Federal Reserve later in the day. Dow Jones industrial average futures were up 0.59 percent at 17,654, S&P 500 futures were up 0.54 percent at 2,056.5 and Nasdaq 100 futures were up 0.52 percent at 4,629.75.
** CHINA FINANCE ONLINE CO LTD, Tuesday close $4.56, +41.23 pct premarket
The web-based financial services company reported a net income for the third quarter, compared with a loss a year earlier, helped by strong revenue from its financial services business.
** ARRAY BIOPHARMA INC, Tuesday close $3.83, +31.33 pct premarket
The company said its experimental drug helped patients with a form of melanoma live longer without their cancer progressing, in an ongoing late-stage study.
** VALEANT PHARMACEUTICALS INTERNATIONAL INC, Tuesday close $109.59, +2.66 pct premarket
The Canadian drugmaker cut its revenue and profit forecasts for 2015, but said it still expected double-digit percentage sales growth through higher volumes in 2016. nL3N1453RF]
** SUNEDISON INC, Tuesday close $4.95, +13.13 pct premarket
** TERRAFORM POWER INC, Tuesday close $12.39, +6.94 pct premarket
** SUNRUN INC, Tuesday close $9.49, +12.96 pct premarket
** SOLARCITY CORP, Tuesday close $40.05, +10.36 pct premarket
** SUNPOWER CORP, Tuesday close $24.42, +6.47 pct premarket
** FIRST SOLAR INC, Tuesday close $59.83, +6.40 pct premarket
Solar companies’ stocks set for the third straight day of gains after the Paris climate agreement. Renewable energy companies are expected to see big upticks in investments to develop new technologies. The solar industry also boosted by an expected extension of investment tax credits beyond 2016 and a California Public Utilities Commission proposal to continue solar customer credits for electricity they contribute to utility grid.
** CELSION CORP, Tuesday close $1.78, +11.24 pct premarket
The drug developer said Chinese health regulators had allowed it to conduct a late-stage study of its experimental liver cancer therapy. Celsion says China market is an important part of its strategy with nearly half of the new liver cancer patients diagnosed each year globally.
** NORTHROP GRUMMAN CORP, Tuesday close $187.84, +1.15 pct premarket
The company riding high after its selection to build the next U.S. long-range bomber, says it is investing heavily and hiring workers as part of a focused plan to unveil at least one “big, bold and ingenious” new technology each year.
** JOY GLOBAL INC, Tuesday close $11.46, -4.28 pct premarket
The mining equipment maker reported fourth-quarter revenue and profit above the average analyst estimates but forecast lower-than-expected 2016 profit and revenue.
** ASTRAZENECA PLC, Tuesday close $33.26, +1.02 pct premarket
The British drugmaker has agreed to buy Takeda Pharmaceutical’s respiratory business, including expanded rights to roflumilast, a treatment for chronic obstructive pulmonary disease (COPD). The company also said it aims to build up its already strong position in China by making and developing more medicines locally, and will invest more than $800 million in the country over the next 10 years. (Compiled by Rosmi Shaji in Bengaluru; Edited by Don Sebastian)